A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD
Clinical trial NCT07275840 · RECRUITING
Trial details
- NCT number
- NCT07275840
- Sponsor
- Innovent Biologics Technology Limited (Shanghai R&D Center)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-05
- Primary completion
- 2026-08-30
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.